MarketInOut Stock Screener Log In | Sign Up
 

Icon Plc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 08/13/2026 16:00
Icon Plc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization12,775 mln
Float74.69 mln
Earnings Date10/28/2026

EPS

0.65
Stretched

P / E

258
Bubble territory

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.56
Likely reliable

1-Year Forecast

186
Modest upside

Relative Strength

44 / 100
Slightly lagging

Business Description

Founded in 1989 and headquartered in Dublin, Ireland, ICON Public Limited Company helps pharmaceutical, biotechnology, medical device, and public health organizations bring new treatments to market. The company manages the full journey of clinical trials, from early compound testing through all phases of development and beyond, offering services that include laboratory work, data analysis, patient access, medical imaging, and regulatory support. ICON also provides consulting, contract staffing, and commercial strategy services to help clients design, run, and complete studies efficiently. The company operates across Europe, the United States, and internationally, and maintains a strategic partnership with Advarra Inc. to build a connected network of trial-ready research sites.

Key Fundamentals

EPS0.65
P/E258
ROE0.45
RPS107
ROIC2.07
ROA0.26
Interest Cover4.50
EBITDA, mln863
EV / EBITDA17.78
EV / EBIT51.93
Revenue, mln8,294
EV / Revenue1.85

Financial Strength

Altman Z-Score1.84
Piotroski F-Score 6 / 9
Beneish M-Score-2.56
Price to Intrinsic Value0.77
Price to Lynch Fair Value4.77
1-Year Target Price186
Shiller PE Ratio24.61
Short Ratio2.69
Short % of Float3.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.92% 77 / 100   
1 Month -2.67% 25 / 100   
2 Months 34.92% 93 / 100   
6 Months 25.79% 85 / 100   
1 Year -0.95% 34 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us